Study focuses on nevirapine HIV therapy (AEGiS.org) - Study focuses on nevirapine HIV therapy
United Press International - March 2, 2010
http://www.aegis.org/news/upi/2010/UP100301.html

BIRMINGHAM, Ala., March 2 (UPI) -- U.S. scientists say women given nevirapine to protect the fetus from HIV should not use that drug for at least a year after childbirth.
University of Alabama at Birmingham researchers said despite nevirapine working well to prevent mother-to-child transmission of the human immunodeficiency virus, a single dose of nevirapine in infected pregnant women can trigger resistance to some forms of the AIDS-drug cocktail known as combination anti-retroviral treatment.
Professor Jeffrey Stringer, who led the study, said the nevirapine-induced resistance fades after about 12 months.
"This study shows that women who need treatment more than 12 months after using nevirapine to prevent mother-to-child transmission safely can use standard first-line treatments in their countries," Stringer said. "Women who need treatment sooner than that should use a combination that does not contain nevirapine, typically (a) regimen that contains protease-inhibitor drugs."
The study that included scientists from Zambia, Nairobi and Bangkok is reported in the journal PLoS Medicine.
100302 UP100301

Copyright © 2010 - United Press International. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through United Press International, Permissions Desk, 1510 H St. N.W. Washington DC 2005. Main Phone Switchboard: 202-898-8000 FAX: 202-898-8057 or 202-898-8147 Email: info@upi.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2010. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2010. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. [AEGiS]